Fundraising Fox
Nanobots Therapeutics
6 known investors
Find your way into Nanobots Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
Ask Júlia Rodríguez-Comas to introduce you to Samuel Sánchez
You →Júlia · together at Institute for Bioengineering of Catalonia (IBEC) →Samuel
Sign up to find every way you can get introduced to Nanobots Therapeutics
- Your email: who you already know at Nanobots Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Nanobots Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Nanobots Therapeutics develops the MotionTx platform to create nanobots that penetrate tissues and enhance drug accumulation in target cells for therapeutic applications. The company is a spin-off of ICREA and IBEC resulting from research by Prof. Samuel Sánchez.
Founders & leadership
Investors · 6
How we know: Capital Cell's portfolio page · Not right? Tell us
How we know: ibecbarcelona.eu · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements- Undisclosed amountPre-Seed funding roundSep 2023
BStartup Health (lead), ACCIÓ StartUp Capital program, ESADE-BAN, Prous Institute for Biomedical Research
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Nanobots Therapeutics do?
- Nanobots Therapeutics develops the MotionTx platform to create nanobots that penetrate tissues and enhance drug accumulation in target cells for therapeutic applications. The company is a spin-off of ICREA and IBEC resulting from research by Prof. Samuel Sánchez.
- Who founded Nanobots Therapeutics?
- Nanobots Therapeutics was founded by Samuel Sánchez.
- Who are Nanobots Therapeutics's investors?
- Nanobots Therapeutics's investors include BStartup, Capital Cell, ESADE BAN.